help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Endocrine Reviews 23 (4): 495
Copyright © 2002 by The Endocrine Society

Meta-Analyses of Therapies for Postmenopausal Osteoporosis

Osteoporosis Methodology Group, 1 the Osteoporosis Research Advisory Group2

I. Introduction and Methodology Ann Cranney, MD, MSc; Peter Tugwell, MD, MSc; George Wells, PhD; Gordon Guyatt, MD, MSc; the Osteoporosis Methodology Group; and the Osteoporosis Research Advisory Group

II. Alendronate Ann Cranney, MD, MSc; George Wells, PhD; Andrew Willan, PhD; Lauren Griffith, MSc; Nicole Zytaruk, RN; Vivian Robinson, MSc; Dennis Black, PhD; Jonathan Adachi, MD; Beverley Shea, BScN, MSc; Peter Tugwell, MD, MSc; Gordon Guyatt, MD, MSc; the Osteoporosis Methodology Group; and the Osteoporosis Research Advisory Group

III. Risedronate Ann Cranney, MD, MSc; Peter Tugwell, MD, MSc; Jonathan Adachi, MD; Bruce Weaver, MSc; Nicole Zytaruk, RN; Alexandra Papaioannou, MD; Vivian Robinson, MSc, Beverley Shea, BScN, MSc; George Wells, PhD; Gordon Guyatt, MD, MSc; the Osteoporosis Methodology Group; and the Osteoporosis Research Advisory Group

IV. Raloxifene Ann Cranney, MD, MSc; Peter Tugwell, MD, MSc; Nicole Zytaruk, RN; Vivian Robinson, MSc; Bruce Weaver, MSc; Jonathan Adachi, MD; George Wells, PhD; Beverley Shea, BScN, MSc; Gordon Guyatt, MD, MSc; the Osteoporosis Methodology Group; and the Osteoporosis Research Advisory Group

V. Hormone Replacement George Wells, PhD; Peter Tugwell, MD, MSc; Beverley Shea, BScN, MSc; Gordon Guyatt, MD, MSc; Joan Peterson, BSc; Nicole Zytaruk, RN; Vivian Robinson, MSc; David Henry, MD; Diane O’Connell, PhD; Ann Cranney, MD, MSc; the Osteoporosis Methodology Group; and the Osteoporosis Research Advisory Group

VI. Calcitonin Ann Cranney, MD, MSc; Peter Tugwell, MD, MSc; Nicole Zytaruk, RN; Vivian Robinson, MSc; Bruce Weaver, MSc; Beverley Shea, BScN, MSc; George Wells, PhD; Jonathan Adachi, MD; Lisa Waldegger; Gordon Guyatt, MD, MSc; the Osteoporosis Methodology Group; and the Osteoporosis Research Advisory Group

VII. Calcium Beverley Shea, BScN, MSc; George Wells, PhD; Ann Cranney, MD, MSc; Nicole Zytaruk, RN; Vivian Robinson, MSc; Lauren Griffith, MSc; Zulma Ortiz, MD; Joan Peterson, Jonathan Adachi, MD; Peter Tugwell, MD; MSc, Gordon Guyatt, MD, MSc; the Osteoporosis Methodology Group; and the Osteoporosis Research Advisory Group

VIII. Vitamin D Emmanuel Papadimitropoulos, PhD; George Wells, PhD; Beverley Shea, BScN, MSc; William Gillespie, MD, MSc; Bruce Weaver, MSc; Nicole Zytaruk, RN; Ann Cranney, MD, MSc; Jonathan Adachi, MD; Peter Tugwell, MD, MSc; Robert Josse, MB, BS; Carol Greenwood, PhD; Gordon Guyatt, MD, MSc; the Osteoporosis Methodology Group; and the Osteoporosis Research Advisory Group

IX. Summary Ann Cranney, MD, MSc; Gordon Guyatt, MD, MSc; Lauren Griffith, MSc; George Wells, PhD; Peter Tugwell, MD, MSc; Clifford Rosen, MD; the Osteoporosis Methodology Group; and the Osteoporosis Research Advisory Group

Series Editor: Gordon H. Guyatt

Correspondence to: Dr. Gordon Guyatt, McMaster University, Department of Clinical Epidemiology and Biostatistics, 1200 Main Street West, Room 2C12, Hamilton, Ontario, L8N 3Z5 Canada. E-mail:

A. Cranney is supported by an Arthritis Society of Canada Research Scholarship.


    Footnotes
 
1 Osteoporosis Methodology Group

Members are Gordon Guyatt, MD, MSc (Chair); Jonathan Adachi, MD; Ann Cranney, MD, MSc; Lauren Griffith, MSc; Jessie McGowan, MLIS; Vivian Robinson, MSc; Beverley Shea, BScN, MSc; Peter Tugwell, MD; Bruce Weaver, MSc; George Wells, PhD; Andrew Willan, PhD; and Nicole Zytaruk, RN. Back

2 Osteoporosis Research Advisory Group

Members are Clifford J. Rosen, MD (Chair); John P. Bilezikian, MD; Dennis M. Black, PhD; Murray J. Favus, MD; Lorraine A. Fitzpatrick, MD; Douglas P. Kiel, MD, MPH; Robert Marcus, MD; Eric S. Orwoll, MD; and Thomas J. Schnitzer, MD, PhD. Back




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
S. R. Majumdar, B. H. Rowe, D. Folk, J. A. Johnson, B. H. Holroyd, D. W. Morrish, W. P. Maksymowych, I. P. Steiner, C. H. Harley, B. J. Wirzba, et al.
A Controlled Trial To Increase Detection and Treatment of Osteoporosis in Older Patients with a Wrist Fracture
Ann Intern Med, September 7, 2004; 141(5): 366 - 373.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals